Locations
South San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2014
Encoded Therapeutics is a biotechnology company focused on developing transformative gene therapies for central nervous system (CNS) disorders. Their innovative genetic medicines aim to address the root causes of these disorders, providing potentially long-lasting benefits. The company utilizes a novel targeting and regulation platform that enhances gene specificity and cell selectivity, setting them apart from first-generation gene therapies. With a strong commitment to patient focus and scientific exploration, Encoded is well-positioned in the gene therapy market, aiming to deliver impactful solutions for patients suffering from severe genetic disorders.
Something looks off?